Drug Profile
Research programme: opioid prodrugs - NeurogesX
Alternative Names: NGX-6052Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator NeurogesX
- Class
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Pain in USA
- 27 Aug 2007 Preclinical trials in Pain in USA (unspecified route)